High ADORA2A RNA expression negatively correlated with colorectal and ovarian cancer. Only 10.7% and 4.7% of colorectal and ovarian cancers, respectively, expressed high ADORA2A levels (≥75 percentile RNA rank) (Table 1 and Figure 2). Here, ADORA2A is linked to ovarian cancer.